CHRISTOPHER SENDI: Open Payments
NPI 1295714475 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 36 payments from 10 companies in 2025. Trend: 2023 $350 · 2024 $739 · 2025 $847
Food & beverage: $835Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $212 |
| ABBVIE INC. | 4 | $87 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Indivior Inc. | 1 | $40 |
| Braeburn Inc. | 2 | $38 |
| TMS NeuroHealth Centers Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $28 |
| PFIZER INC. | 1 | $23 |
Products named: CAPLYTA, HETLIOZ, FANAPT, VRAYLAR, Auvelity, TRINTELLIX, SUBLOCADE, BRIXADI.
Industry payments across VA — which companies pay providers there.
